Design and optimization of coagulation factor XIa inhibitors: Discovery of trans-N-((S)-1-(4-(3-amino-1H-indazol-6-yl)-5-chloro-1H-imidazol-2-yl)-2-phenylethyl)-4-(aminomethyl)cyclohexane-carboxamide, a potent factor XIa inhibitor with in vivo antithrombotic activity

被引：0
|
作者：
Hangeland, Jon J. [1 ]
Friends, Todd J. [1 ]
Rossi, Karen A. [1 ]
Smallheer, Joanne M. [1 ]
Wang, Cailan [1 ]
Sun, Zhong [1 ]
Fang, Tianan [1 ]
Corte, James R. [1 ]
Wong, Pancras C. [1 ]
Rendina, Alan R. [1 ]
Luettgen, Joseph M. [1 ]
Barbera, Frank A. [1 ]
Bozarth, Jeffrey M. [1 ]
Watson, Carol A. [1 ]
Zhang, Ge [1 ]
Wei, Anzhi [1 ]
Morin, Paul F. [1 ]
Bisacchi, Gregory S. [1 ]
Seiffert, Dietmar A. [1 ]
Wexler, Ruth R. [1 ]
Quan, Mimi L. [1 ]
机构：
[1] Bristol Myers Squibb Co, Res & Dev, Princeton, NJ 08543 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2014年 / 247卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
216-MEDI
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Discovery of (S)-1-(1-(4-Chloro-3-fluorophenyl)-2-hydroxyethyl)-4-(2-((1-methyl-1H-pyrazol-5-yl)amino)pyrimidin-4-yl)pyridin-2(1H)-one (GDC-0994), an Extracellular Signal-Regulated Kinase 1/2 (ERK1/2) Inhibitor in Early Clinical Development
    Blake, James F.
    Burkard, Michael
    Chan, Jocelyn
    Chen, Huifen
    Chou, Kang-Jye
    Diaz, Dolores
    Dudley, Danette A.
    Gaudino, John J.
    Gould, Stephen E.
    Grina, Jonas
    Hunsaker, Thomas
    Liu, Lichuan
    Martinson, Matthew
    Moreno, David
    Mueller, Lars
    Orr, Christine
    Pacheco, Patricia
    Qin, Ann
    Rasor, Kevin
    Ren, Li
    Robarse, Kirk
    Shahidi-Latham, Sheerin
    Stults, Jeffrey
    Sullivan, Francis
    Wang, Weiru
    Yin, Jianping
    Zhou, Aihe
    Belvin, Marcia
    Merchant, Mark
    Moffat, John
    Schwarz, Jacob B.
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (12) : 5650 - 5660
  • [32] Discovery of 1-[3-(aminomethyl)phenyl]-N-[3-fluoro-2′- (methylsulfonyl)-[1,1′-biphenyl]-4-yl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide (DPC423), a highly potent, selective, and orally bioavailable inhibitor of blood coagulation factor Xa
    Pinto, DJP
    Orwat, MJ
    Wang, SG
    Fevig, JM
    Quan, ML
    Amparo, E
    Cacciola, J
    Rossi, KA
    Alexander, RS
    Smallwood, AM
    Luettgen, JM
    Liang, L
    Aungst, BJ
    Wright, MR
    Knabb, RM
    Wong, PC
    Wexler, RR
    Lam, PYS
    JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (04) : 566 - 578
  • [33] Discovery of (3S, 4R)-1-(1-(2-chloro-6-cyclopropylbenzoyl)-4-fluoro-1H-indazol-3-yl)-3-hydroxypiperidine-4-carboxylic acid as potent and selective allosteric inhibitors of ROR.t for the treatment of autoimmune diseases
    Zhang, Hongjun
    Barr, Kenneth
    Anthony, Neville
    Correll, Craig
    Ferguson, Heidi
    Parthasarathy, Gopal
    Maclean, John
    Richard, Miller
    Trotter, B. Wesley
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
  • [34] Discovery of (R)-4-(8-Fluoro-2-oxo-1,2-dihydroquinazolin-3(4H)-yl)-N-(3-(7-methyl-1H-indazol-5-yl)-1-oxo-1-(4-(piperidin-1-yl)piperidin-1-yl)propan-2-yl)piperidine-1-carboxamide (BMS-694153):: A potent antagonist of the human calcitonin gene-related peptide receptor for migraine with rapid and efficient intranasal exposure
    Degnan, Andrew P.
    Chaturvedula, Prasad V.
    Conway, Charles M.
    Cook, Deborah A.
    Davis, Carl D.
    Denton, Rex
    Han, Xiaojun
    Macci, Robert
    Mathias, Neil R.
    Moench, Paul
    Pin, Sokhoin S.
    Ren, Shelly X.
    Schartman, Richard
    Signor, Laura J.
    Thalody, George
    Widmann, Kimberly A.
    Xu, Cen
    Macor, John E.
    Dubowchik, Gene M.
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (16) : 4858 - 4861
  • [35] Crystal structure of 3-(adamantan-1-yl)-1-[(4-benzylpiperazin-1-yl)methyl]-4-[(E)-(2,6-difluorobenzylidene)amino]-1H-1,2,4-triazole-5(4H)-thione, C31H36F2N6S
    Al-Alshaikh, Monirah A.
    Ghabbour, Hazem A.
    Abuelizz, Hatem A.
    Alruqi, Obaid S.
    El-Emam, Ali A.
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2016, 231 (03): : 927 - 929
  • [36] Design and Development of Novel 4-(4-(1H-Tetrazol-5-yl)-1H-pyrazol-1-yl)-6-morpholino-N-(4-nitrophenyl)-1,3,5-triazin-2-amine as Cardiotonic Agent via Inhibition of PDE3
    Mao, Zhi-Wei
    Li, Qiao-Ling
    Wang, Ping
    Sun, Yang-Li
    Liu, Yu
    ARCHIV DER PHARMAZIE, 2016, 349 (04) : 268 - 276
  • [37] Catalytic synthesis and antimicrobial activity of N-(3-chloro-2-oxo-4-phenylazetidin-1-yl)-4-(1H-indol-3-yl)-6-methyl-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carboxamides
    Desai, Nisheeth C.
    Bhatt, Malay J.
    HETEROCYCLIC COMMUNICATIONS, 2016, 22 (03) : 131 - 136
  • [38] Discovery of trans-N-[1-(2-fluorophenyl)-3-pyrazolyl]-3-oxospiro-[6-azaisobenzofuran-1(3H),1′-cyclohexane]-4′-carboxamide, a potent and orally active neuropeptide Y Y5 receptor antagonist
    Haga, Yuji
    Sakamoto, Toshihiro
    Shibata, Takunobu
    Nonoshita, Katsumasa
    Ishikawa, Makoto
    Suga, Takuya
    Takahashi, Hirobumi
    Takahashi, Toshiyuki
    Takahashi, Hidekazu
    Ando, Makoto
    Murai, Takashi
    Gomori, Akira
    Oda, Zenjun
    Kitazawa, Hidefumi
    Mitobe, Yuko
    Kanesaka, Maki
    Ohe, Tomoyuki
    Iwaasa, Hisashi
    Ishii, Yasuyuki
    Ishihara, Akane
    Kanatani, Akio
    Fukami, Takehiro
    BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (19) : 6971 - 6982
  • [39] Antimycobacterial activity of new N1-[1-[1-aryl-3-[4-(1H-imidazol-1-yl)phenyl]-3-oxo]propyl]-pyridine-2-carboxamidrazone derivatives
    Zampieri, Daniele
    Mamolo, Maria Grazia
    Vio, Luciano
    Romano, Maurizio
    Skoko, Natasa
    Baralle, Marco
    Pau, Valentina
    De Logu, Alessandro
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (14) : 3287 - 3290
  • [40] 4-((5-(1-(4-Fluorophenyl)-5-methyl-1H-1,2,3-triazol-4-yl)-1,3,4-thiadiazol-2-yl)amino)benzenesulfonic acid: unexpected synthesis, structure elucidation and antimicrobial activity
    Kariuki, Benson M.
    Mohamed, Hanan A.
    Abdel-Wahab, Bakr F.
    El-Hiti, Gamal A.
    PHOSPHORUS SULFUR AND SILICON AND THE RELATED ELEMENTS, 2023, 198 (01) : 10 - 14
12345